Current applications of artificial intelligence in assisted reproductive technologies through the perspective of a patient's journey.

Abstract

This review highlights the timely relevance of artificial intelligence in enhancing assisted reproductive technologies (ARTs), particularly in-vitro fertilization (IVF). It underscores artificial intelligence's potential in revolutionizing patient outcomes and operational efficiency by addressing challenges in fertility diagnoses and procedures. Recent advancements in artificial intelligence, including machine learning and predictive modeling, are making significant strides in optimizing IVF processes such as medication dosing, scheduling, and embryological assessments. Innovations include artificial intelligence augmented diagnostic testing, predictive modeling for treatment outcomes, scheduling optimization, dosing and protocol selection, follicular and hormone monitoring, trigger timing, and improved embryo selection. These developments promise to refine treatment approaches, enhance patient engagement, and increase the accuracy and scalability of fertility treatments. The integration of artificial intelligence into reproductive medicine offers profound implications for clinical practice and research. By facilitating personalized treatment plans, standardizing procedures, and improving the efficiency of fertility clinics, artificial intelligence technologies pave the way for value-based, accessible, and efficient fertility services. Despite the promise, the full potential of artificial intelligence in ART will require ongoing validation and ethical considerations to ensure equitable and effective implementation.